Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Nederlands Tijdschrift Voor Geneeskunde|August 7, 2020
[Which side effects should I inform patients about?]M O Reumerman, E P van Puijenbroek, J M Janson, et al.
The American Journal of Tropical Medicine and Hygiene|September 25, 1999
The development of an immunoassay for the detection of artemisinin compounds in urineT A Eggelte, M A van Agtmael, T D Vuong, et al.
Clinical Pharmacology and Therapeutics|November 5, 1999
The effect of grapefruit juice on the time-dependent decline of artemether plasma levels in healthy subjectsM A van Agtmael, V Gupta, C A van der Graaf, et al.
The Journal of Infectious Diseases|September 1, 1995
Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidimeJ M Prins, M A van Agtmael, E J Kuijper, et al.
International Journal of Antimicrobial Agents|July 27, 1999
Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malariaM A van Agtmael, S Cheng-Qi, J X Qing, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 24, 2006
The role of procalcitonin in a decision tree for prediction of bloodstream infection in febrile patientsR P H Peters, J W R Twisk, M A van Agtmael, et al.
European Journal of Clinical Pharmacology|May 12, 2021
The potential of training specialist oncology nurses in real-life reporting of adverse drug reactionsM Reumerman, J Tichelaar, R van Eekeren, et al.
European Journal of Clinical Pharmacology|August 24, 1999
Grapefruit juice increases the bioavailability of artemetherM A van Agtmael, V Gupta, T H van der Wösten, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 8, 1998
The contribution of the enzymes CYP2D6 and CYP2C19 in the demethylation of artemether in healthy subjectsM A van Agtmael, C A Van Der Graaf, T K Dien, et al.
The Netherlands Journal of Medicine|September 24, 2008
5-Oxoproline as a cause of high anion gap metabolic acidosis: an uncommon cause with common risk factorsW Kortmann, M A van Agtmael, J van Diessen, et al.
Pageof 4